CHEK2 and thyroid gland undifferentiated (anaplastic) carcinoma: A case-control study of patients with non-anaplastic thyroid cancer in an Iranian population found no germline CHEK2 mutations in cases nor controls, though this probably reflects the low frequency of CHEK2 mutations in the Middle Eastern population [15].